Everence Capital Management’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $213K | Hold |
12,896
| – | – | 0.01% | 799 |
|
|
2026
Q1 | $210K | Sell |
12,896
-2,314
| -15% | -$36.2K | 0.01% | 739 |
|
|
2025
Q4 | $226K | Hold |
15,210
| – | – | 0.01% | 704 |
|
|
2025
Q3 | $195K | Hold |
15,210
| – | – | 0.01% | 775 |
|
|
2025
Q2 | $231K | Hold |
15,210
| – | – | 0.01% | 695 |
|
|
2025
Q1 | $254K | Hold |
15,210
| – | – | 0.02% | 641 |
|
|
2024
Q4 | $287K | Sell |
15,210
-16,045
| -51% | -$309K | 0.02% | 598 |
|
|
2024
Q3 | $587K | Hold |
31,255
| – | – | 0.04% | 374 |
|
|
2024
Q2 | $478 | Hold |
31,255
| – | – | 0.03% | 404 |
|
|
2024
Q1 | $508 | Hold |
31,255
| – | – | 0.03% | 402 |
|
|
2023
Q4 | $396K | Hold |
31,255
| – | – | 0.03% | 476 |
|
|
2023
Q3 | $426 | Hold |
31,255
| – | – | 0.03% | 437 |
|
|
2023
Q2 | $461K | Hold |
31,255
| – | – | 0.04% | 368 |
|
|
2023
Q1 | $435 | Hold |
31,255
| – | – | 0.04% | 409 |
|
|
2022
Q4 | $418 | Hold |
31,255
| – | – | 0.04% | 432 |
|
|
2022
Q3 | $372K | Hold |
31,255
| – | – | 0.03% | 444 |
|
|
2022
Q2 | $398K | Hold |
31,255
| – | – | 0.04% | 426 |
|
|
2022
Q1 | $404K | Hold |
31,255
| – | – | 0.03% | 477 |
|
|
2021
Q4 | $495K | Hold |
31,255
| – | – | 0.04% | 425 |
|
|
2021
Q3 | $609K | Hold |
31,255
| – | – | 0.05% | 325 |
|
|
2021
Q2 | $712K | Hold |
31,255
| – | – | 0.06% | 274 |
|
|
2021
Q1 | $574K | Sell |
31,255
-14,403
| -32% | -$236K | 0.05% | 321 |
|
|
2020
Q4 | $680K | Hold |
45,658
| – | – | 0.07% | 248 |
|
|
2020
Q3 | $512K | Sell |
45,658
-19,580
| -30% | -$193K | 0.06% | 280 |
|
|
2020
Q2 | $567K | Hold |
65,238
| – | – | 0.07% | 250 |
|
|
2020
Q1 | $527K | Hold |
65,238
| – | – | 0.07% | 226 |
|
|
2019
Q4 | $820K | Hold |
65,238
| – | – | 0.12% | 176 |
|
|
2019
Q3 | $582K | Hold |
65,238
| – | – | 0.09% | 230 |
|
|
2019
Q2 | $558K | Hold |
65,238
| – | – | 0.09% | 230 |
|
|
2019
Q1 | $495K | Buy |
65,238
+43,578
| +201% | +$350K | 0.09% | 243 |
|
|
2018
Q4 | $179K | Hold |
21,660
| – | – | 0.04% | 384 |
|
|
2018
Q3 | $215K | Hold |
21,660
| – | – | 0.04% | 397 |
|
|
2018
Q2 | $212K | Hold |
21,660
| – | – | 0.04% | 390 |
|
|
2018
Q1 | $201K | Hold |
21,660
| – | – | 0.04% | 397 |
|
|
2017
Q4 | $206K | Hold |
21,660
| – | – | 0.05% | 390 |
|
|
2017
Q3 | $224K | Hold |
21,660
| – | – | 0.05% | 336 |
|
|
2017
Q2 | $179K | Hold |
21,660
| – | – | 0.04% | 356 |
|
|
2017
Q1 | $156K | Buy |
+21,660
| New | +$157K | 0.04% | 342 |
|
Other funds holding SEM
GCL
AA
DAM
PAMP
Everence Capital Management's SEM Position: Q2 2026 in Review
Everence Capital Management held its Select Medical (SEM) position steady in Q2 2026 at 12,896 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #799.
Everence Capital Management first reported a position in SEM in Q1 2017 and has held it in 38 quarters since. The position peaked at $820K in Q4 2019. 239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- Everence Capital Management held 12,896 shares of Select Medical worth $213K as of Q2 2026.
- Everence Capital Management left its Select Medical share count unchanged in Q2 2026.
- Select Medical made up 0.01% of Everence Capital Management's portfolio in Q2 2026, its #799 holding.
- Everence Capital Management first reported a position in Select Medical in Q1 2017 and has held it in 38 quarters since.
- Everence Capital Management's Select Medical position peaked at $820K in Q4 2019.
- 239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.